Got $10,000 to Invest? These Top TSX Stocks Could Double

These stocks have the potential to double investors’ money in the medium to long term.

| More on:
Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

If you’re wondering where to invest $10,000 that could double in mid- to long term, zoom in on these top TSX high-growth stocks. These companies have reported robust revenue growth in the past, which has driven their stocks higher. Moreover, the momentum in their business could be sustained, implying that the rally in their stocks could continue in the coming years.

Kinaxis

With its predictable recurring revenue base, which has increased rapidly in the past, and strong profitability and cash position, Kinaxis (TSX:KXS) remains the top stock that could turn your $10,000 investment into $20,000 in the medium to long term.

Its fast acquisition of new customers and multi-year subscription agreements have driven its revenues higher in the past. Investors should note that Kinaxis’s top line has grown at a compound annual growth rate (CAGR) of over 20% from 2015 to 2019. Meanwhile, its revenues have marked 30% growth in the first six months of 2020, which is encouraging.

Its adjusted EBITDA has grown at a CAGR of 16% from 2015 to 2019. Meanwhile, it has nearly doubled in the first half of 2020.

Kinaxis’s continued investment in innovation and expansion to new geographies could continue to drive the demand for its supply-chain software. Meanwhile, its acquisition of Rubikloud adds a new target market, which could bolster its growth further.

The company’s growing blue-chip customer base, strong order backlog, and high customer retention rate suggest that Kinaxis stock could continue to outperform the broader markets in the coming years and could generate stellar returns for its shareholders.

Dye & Durham

The newly listed Dye & Durham (TSX:DND) stock has proven that its resilient and high growth business is likely to generate some serious gains for its shareholders. Dye & Durham stock has nearly doubled from its IPO price of $7.50, thanks to its robust performance and strong prospects.

Dye & Durham, which provides legal and business professionals access to public records and critical information, has witnessed a strong demand for cloud-based software and technology solutions. Its top line has grown at a CAGR of about 71% from the fiscal year 2016 to 2019. During the same period, its adjusted EBITDA grew at a CAGR of 136%. As for the 12-month ending June 30, its revenues increased by 49% year over year.

Investors should note that lower economic activity and the temporary closure of courthouses amid COVID-19 pandemic weighed on its transactions and, in turn, its revenue growth rate. However, investors could expect Dye & Durham’s revenue and EBITDA growth to accelerate as the economic activities increase. Further, its acquisitions, addition of new customers, and low churn rate suggest that Dye & Durham could post stellar growth in the coming years.

Enghouse Systems

With its enterprise software solutions supporting remote work, communications, and visual computing, Enghouse Systems (TSX:ENGH) stock should be on your radar to create wealth. Enghouse is witnessing robust demand for its platform amid the structural shift towards working from home and distance learning. Moreover, the demand for its platform is likely to be sustained, even in the post-pandemic era.

The strength in its base business, accretive acquisitions, and strong operational efficiencies position it well to generate stellar sales and earnings in the coming years, which should support the rally in its stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned. The Motley Fool recommends Enghouse Systems Ltd. and KINAXIS INC.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »